发现性传播疾病的活性化疗剂,以抑制致病性HPV-16-E6蛋白
Vemula Vani1, Manikandan Alagumuthu2, Sanjay Prasad3
1Department of Microbiology, MS Ramaiah College of Arts, Science and Commerce, Bangalore, 560054, India.
Current drug discovery technologies
|February 11, 2025
概括
虚拟查确定了四种有前途的类似药物的化合物作为人类乳头瘤病毒16型 (HPV16) E6蛋白的潜在抑制剂,为HPV治疗提供了新的途径.
科学领域:
- 计算化学和药物发现
- 瘤学和病毒学.
- 药品化学 药品化学 是一个
背景情况:
- 人类乳头瘤病毒 (HPV) 感染是一种流行性传播疾病,与癌症有关.
- 目前的HPV治疗包括化疗或手术;然而,价格实惠的基于药物的疗法正在出现.
- HPV E6蛋白与E6AP相互作用,形成一个促进癌症发生的p53降解复合体.
研究的目的:
- 通过虚拟查识别潜在的小分子抑制剂,以HPV16 E6蛋白为向.
- 发现针对HPV相关疾病的新型治疗剂.
主要方法:
- 基于碎片的药物设计被用来创建三个新的HPV16 E6抑制剂.
- 使用Schrodinger软件对ZINC数据库进行了虚拟选,随后进行了MD模拟和DFT.
- 一个9800次点击的子集通过三个虚拟选阶段进行过.
主要成果:
- 五个受影响的化合物与黄素相比,呈现出更高的滑行得分,与HPV16 E6蛋白有显著的相互作用.
- 所有五种化合物的药理动力学特性和口服吸收都令人满意.
- 四种化合物 (ZINC000034853956,ZINC000001534965,ZINC000095617673,ZINC000071606215) 显示具有类似药物的特性,没有预测的毒性.
结论:
- 四种已识别的化合物作为开发HPV16 E6抑制剂的有希望的分子.
- 这些化合物为针对HPV相关疾病的新型治疗策略提供了潜力.
相关概念视频
01:30Cancer Vaccines
329
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329
01:26Sexually Transmitted Infections
261
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
261
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:33Initiation of Translation
30.4K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
30.4K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K